Pharma News, 2025

FDA Grants Fast Track Status to SIGX1094 for Diffuse Gastric Cancer

Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025

Japanese researchers enhance mRNA cancer drugs' protein synthesis efficiency by 200 times

Telomir Pharmaceuticals announced results from its recent preclinical studies conducted in human retinal cell lines.  These studies demonstrated the ability of Telomir-1 to significantly rev...

Innate’s lacutamab gains FDA breakthrough therapy designation

FDA grants Fast Track Status to Rznomics’ RZ-001 for the treatment of hepatocellular carcinoma

Drug Discovery Preclinical CRO Market Growth Accelerating at 6.17% CAGR to 30.5 Billion USD by 2032

GSK’s Penmenvy meningococcal vaccine gains FDA approval

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

Galderma enters fierce European atopic dermatitis market with Nemluvio approval

Cell therapy weekly: preclinical programs for tumor-activated immunotherapies